- 全部删除
您的购物车当前为空
GSK-3 inhibitor 4 是一种具有口服活性和脑渗透性的 GSK-3,CDK2 和 CDK5 三重抑制剂,对 GSK-3β,GSK-3α,CDK2 和 CDK5 具有抑制作用,IC50 值分别为 0.56 nM ,0.45 nM ,0.47 μM,0.68 μM。GSK-3 inhibitor 4 可有效降低 Tau protein 水平。GSK-3 inhibitor 4 可用于研究阿尔茨海默症 。

GSK-3 inhibitor 4 是一种具有口服活性和脑渗透性的 GSK-3,CDK2 和 CDK5 三重抑制剂,对 GSK-3β,GSK-3α,CDK2 和 CDK5 具有抑制作用,IC50 值分别为 0.56 nM ,0.45 nM ,0.47 μM,0.68 μM。GSK-3 inhibitor 4 可有效降低 Tau protein 水平。GSK-3 inhibitor 4 可用于研究阿尔茨海默症 。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,350 | In stock | |
| 5 mg | ¥ 6,370 | In stock | |
| 10 mg | ¥ 8,550 | In stock | |
| 25 mg | ¥ 11,200 | In stock |
GSK-3 inhibitor 4 相关产品
| 产品描述 | GSK-3 inhibitor 4 is an orally active and brain-permeable triple inhibitor of GSK-3, CDK2 and CDK5 with inhibitory effects on GSK-3β, GSK-3α, CDK2 and CDK5, with IC50 values of 0.56 nM, 0.45 nM, 0.47 μM, 0.68 μM, respectively.GSK-3 inhibitor 4 can effectively reduce Tau protein levels. GSK-3 inhibitor 4 can effectively reduce the level of Tau protein.GSK-3 inhibitor 4 can be used in the study of Alzheimer's disease. |
| 靶点活性 | GSK-3β:0.56 nM, GSK-3α:0.45 nM, CDK5:0.68 μM, CDK2:0.47 μM |
| 体外活性 | GSK-3 inhibitor 4针对CDK2(840倍,IC50=0.47μM)、CDK5(1200倍,IC50=0.68μM)、GSK-3β(IC50=0.56nM)及GSK-3α(IC50=0.45nM)展现出极佳的选择性。[1] 该抑制剂因其亲脂性,具有良好的渗透性,并显示出高度结合血浆蛋白和大脑组织的能力。[1] |
| 体内活性 | GSK-3 inhibitor 4(10 mg/kg;p.o.)通过口服纳米悬浮液形式给药,剂量为10 mg/kg时,能将pTau396降低37%。GSK-3 inhibitor 4(2 mg/kg,i.v.;10 mg/kg,p.o.)展现了低至中等的清除率,其范围为15.8至23.3 mL/min/kg,当以溶液形式口服给药时,吸收良好。[1] |
| 分子量 | 403.38 |
| 分子式 | C22H15F2N5O |
| CAS No. | 2227279-83-4 |
| Smiles | N(C(=O)C1=NC(NC2=CC=C(F)C=C2)=NC=C1)C=3C(=CC=NC3)C4=CC=C(F)C=C4 |
| 密度 | 1.401 g/cm3 at 20℃ (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 50 mg/mL (123.95 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容